Table 1.
Clinical features | Case number (N) | CRC patients (N = 288) | X2 | P value | OR | 95% CI | |
---|---|---|---|---|---|---|---|
Metastasis/recurrence (N = 107) | Non‐metastasis/recurrence (N = 181) | ||||||
Gender (n) | |||||||
Male | 143 | 50 (34.97%) | 93 (65.03%) | 0.5822 | .445 | 1.205 | 0.746‐1.945 |
Female | 145 | 57 (39.31%) | 88 (60.69%) | ||||
Age (years old) | |||||||
<60 | 177 | 72 (40.68%) | 105 (59.32%) | 2.444 | .118 | 0.672 | 0.407‐1.108 |
≥60 | 111 | 35 (31.53%) | 76 (68.47%) | ||||
Timor size (cm) | |||||||
≤5 | 147 | 41 (27.89%) | 106 (72.11%) | 11.03 | <.001* | 2.275 | 1.395‐3.711 |
>5 | 141 | 66 (46.81%) | 75 (53.19%) | ||||
Differentiation degree (n) | |||||||
Moderate + high | 186 | 60 (32.26%) | 126 (67.74%) | 5.389 | .0203* | 1.795 | 1.093‐2.947 |
Poor | 102 | 47 (46.08%) | 55 (53.92%) | ||||
Infiltration into serosa (n) | |||||||
No | 84 | 23 (27.38%) | 61 (72.62%) | 9.051 | .0026* | 2.345 | 1.336‐4.115 |
Yes | 179 | 84 (46.93%) | 95 (53.07%) | ||||
Dukes stage (n) | |||||||
A + B | 107 | 21 (19.63%) | 86 (80.37%) | 22.4 | <.001* | 3.707 | 2.119‐6.486 |
C + D | 181 | 86 (47.51%) | 95 (52.49%) |
Abbreviations: CI, confidence interval; CRC, colorectal cancer; OR, odd ratio.
Statistical significance when P value was smaller than .05.